Bushen-Tiansui Formula Improves Cognitive Functions in an Aβ1–42 Fibril-Infused Rat Model of Alzheimer’s Disease [PDF]
, 2020 Chenxia Sheng +5 more
openalex +1 more source
Associations between structural/social determinants of health and vulnerability for and resilience against Alzheimer’s disease and related dementias: The Healthy Brain Initiative [PDF]
, 2023 Lilah M. Besser +8 more
openalex +1 more source
, 2019 Figure S2. Effects of the treatment with an anti-TNFSF10 monoclonal antibody on the expression of FoxP3, as well as the anti-inflammatory protein IL-10 in the hippocampus of 3xTg-AD mice. Immunofluorescence by confocal microscopy of hippocampi for IL-10 and FoxP3 expression and co-localization from the same animal groups as above (merge column; DAPIâ ...
Benedetto, Giulia Di +8 more
openaire +1 more source
, 2019 Table S1. Participantsâ family mutations. (DOCX 17 kb)
Weston, Philip +12 more
openaire +1 more source
Caregiver Education and Service Utilization in African American Families Dealing with Dementia [PDF]
, 2004 For more than a decade attention has been focused on Alzheimer’s family caregivers in African American communities. The Fourth Report of the Advisory Panel on Alzheimer’s Disease to the U. S. Congress and the U.S.
Coogle, Constance L.
core
, 2017 Cost-effectiveness of cerebrospinal biomarkers for Alzheimerâ s diagnosis: supplemental Methods, Results, figures and tables as referenced in the text. (DOCX 91 kb)
Lee, Spencer +3 more
openaire +1 more source
Nutraceuticals in cognitive impairment and Alzheimer’s disease
Frontiers in Pharmacology, 2014 Several chemical substances belonging to classes of natural dietary origin display protective properties against some age-related diseases including neurodegenerative ones, particularly Alzheimer's disease (AD). These compounds, known as nutraceuticals, differ structurally, act therefore at different biochemical and metabolic levels and have shown ...
Mecocci, P. +3 more
openaire +3 more sources
Forecasting the Progression of Alzheimer's Disease Using Neural Networks and a Novel Pre-Processing Algorithm [PDF]
, 1979 Alzheimer's disease (AD) is the most common neurodegenerative disease in older people. Despite considerable efforts to find a cure for AD, there is a 99.6% failure rate of clinical trials for AD drugs, likely because AD patients cannot easily be ...
Albright, Jack
core +14 more sources
, 2019 Figure S7. Negative controls for Fig. 8, panel b (phosphorylated Tau protein expression). Negative controls are reported in all panels marked with acronyms of secondary antibodies labeled with, Alexa Fluor 488. (PDF 491 kb)
Benedetto, Giulia Di +8 more
openaire +1 more source
Subclinical but high level of glycemia and platelet activity are associated with decreased structural and functional integrity in Alzheimer’s disease‐sensitive brain regions [PDF]
, 2021 Cassandre Palix +12 more
openalex +1 more source